Naproxen solution 1.0 mg/ml in methanol

(S)-Naproxen; (+)-Naproxen; (S)-(+)-6-Methoxy-alpha-methyl-2-naphthalene acetic acid; Equiproxen; Laraflex

Liquid. 1mg/ml in methanol.

22204-53-1

3

32160000

liquid

GHS02,GHS06

Protect from light and moisture.

H225-H301 + H311 + H331-H370

InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1

CMWTZPSULFXXJA-VIFPVBQESA-N

Chemical. CAS: 22204-53-1. Formula: C14H14O3. MW: 230.26. Naproxen is a potent, non-steroidal, non-selective anti-inflammatory cyclooxygenase (COX-1 and COX-2) inhibitor. Inhibits COX-1 expression in HUVECS at a concentration of 5µg/ml. This COX inhibitor is indicated for the treatment of pain, fever, inflammation and stiffness. Research indicates that the S-naproxen is a more active form than the R-naproxen. The S-naproxen enantiomer was observed to inhibit platelet aggregation, and both enantiomers decrease production of thromboxane B2. Naproxen has been demonstrated to block A? fibril growth and form a complex with copper (II).

MFCD00010500

C14H14O3

230.26

Vial

III

P210-P260-P280-P301 + P310-P311

Naproxen is a potent, non-steroidal, non-selective anti-inflammatory cyclooxygenase (COX-1 and COX-2) inhibitor. Inhibits COX-1 expression in HUVECS at a concentration of 5µg/ml. This COX inhibitor is indicated for the treatment of pain, fever, inflammation and stiffness. Research indicates that the S-naproxen is a more active form than the R-naproxen. The S-naproxen enantiomer was observed to inhibit platelet aggregation, and both enantiomers decrease production of thromboxane B2. Naproxen has been demonstrated to block A? fibril growth and form a complex with copper (II).

>98% (HPLC)

Danger

C[C@H](C(O)=O)C1=CC2=CC=C(OC)C=C2C=C1

Soluble in aqueous buffers.

Synthetic.

Excepted Quantity

1230

Biochemical Reagents

12352200

Stable for at least 2 years after receipt when stored at +4°C.